Insulet Corporation (PODD) Stock Analysis

Company Overview

The market values Insulet Corporation (PODD) at $10.23B. The company sits in the Healthcare sector, in the Medical Devices industry. Headcount on file is 5,400.

Over the past 52 weeks the price has ranged from $126.40 to $354.88. PODD last closed at $147.48 on September 4, 2026. That is −$3.10 (−2.06%) against the previous close. The latest close sits 16.68% above that 52-week low.

Financial Health

In fiscal 2025, Insulet Corporation reported revenue of $2.71B. Against the prior fiscal year total of $2.07B, that is a change of +30.73%. The same year closed with net income of $247.10M. That is −40.93% against the prior fiscal year. Profit margin runs at 12.29%. That is 14 percentage points above the Medical Devices median of −1.69%. Trailing earnings per share are 5.22.

Across the 4 fiscal years on file, revenue moves from $1.31B in 2022 to $2.71B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

On trailing earnings, the shares are priced at 28.25 times earnings. That is 5.41% above the Medical Devices median of 26.8. On forward earnings the ratio is 19.13. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.18. Measured against sales, the shares trade at 3.35 times revenue. On price-to-sales that is 12.56% above the Medical Devices median of 2.98. The medians here are taken across 151 Medical Devices companies that report the metric.

The reported beta is 1.08. Daily returns over the trailing 10 years annualize to a volatility of 42.8%. Over the trailing twelve months the price has returned −57.43%. Measured over 10 years, that is +13.09% a year compounded.

Growth & Income

The record shows no dividend for PODD.

The strongest complete calendar year on file is 2019 at +115.83%; the weakest is 2023 at −26.30%. Of the 9 complete calendar years on file, 8 finished higher. So far in 2026 the price is −48.11%.